Wednesday, October 30, 2024

9:30 AM - 10:00 AM

---

Overview

Sponsored by: CSL

---

Details

As heart disease remains one of the leading causes of death globally, developing a fully functional artificial heart is a critical step forward in saving lives. This session explores the groundbreaking journey of developing a fully functional artificial heart to replace a failing human heart. It will address the complexities of replicating the heart’s natural functions and the critical risks involved in implementing such a concept into reality. The session also highlights how cutting-edge technologies played a big role in translating the BiVACOR concept from early research to its first in human implants. Key topics include: The risk of artificial heart development The challenges involved in replacing a failing human heart The role of cutting-edge technologies in achieving clinical success This session aims to provide an overview of the complexities and breakthroughs in artificial heart innovation and their implications for the future of cardiovascular treatments. The Millis Oration is named in honour of Emeritus Professor Nancy Millis's contribution to the industry, and it is a focal point of the annual industry gathering, appropriately named after this pioneer of Australia’s biotechnology industry. It is held annually at the conference together with continuous support from CSL.

---

Speaker